Vancouver, BC V6C 1G8 To buy shares in , you'll need to have an account. Algernon to share interim data from Phase 2b/3 human study of Ifenprodil to... Algernon wins Data and Safety Monitoring Board approval to continue its... Algernon announces 25% enrollment for its Phase 2 idiopathic pulmonary... Algernon Pharmaceuticals names Dr Mark Swaim to its medical and scientific... NA Proactive news snapshot: Agraflora Organics, Nerds On Site, Altamira... Algernon enrolls 100 patients for its Phase 2b/3 human study of Ifenprodil... Algernon enrolls 50% of patients in multinational Phase 2b/3 human study of... Algernon Pharmaceuticals gets green light to continue its Phase 2b/3... Proactive virtual event to showcase four companies on the fast track to growth, Algeron Pharmaceuticals in the spotlight with lead drug Ifenprodil as promising coronavirus therapy, Algernon Pharmaceuticals will provide interim data from Ifenprodil Phase 2b/3 human study, Algernon Pharmaceuticals gets green light from data and safety board to continue Phase 2b-3 study, Algernon Pharmaceuticals provides update on Phase 2B/3 study as they enroll 50th patient, Proactive One2One Virtual Event - Algernon Pharmaceuticals. As of Small Cap Pro. $49.05. Free trial. Our analysts have selected this fund for the Wealth Shortlist. and the price has moved by The Company’s drug discovery approach is based on the concept of drug repurposing. here to help. Algernon Pharmaceuticals is a clinical stage pharmaceutical development company focused on the areas of non–alcoholic steatohepatitis (NASH), chronic kidney disease (CKD) and inflammatory bowel disease (IBD). To buy shares in Algernon Pharmaceuticals Inc you'll need a share-dealing account with an online or offline stock broker. For more information, learn about our StockRank Styles. for only . The firm says repurposed compounds have a much lower risk of failing in human trials on safety issues. wellbeing and our community we're You can read more about the power of momentum in assessing share price movements on Stockopedia. An important predictor of whether a stock price will go up is its track record of momentum. Algernon Pharmaceuticals: Algernon Pharmaceuticals Announces Plans to Provide Interim Data from its Ifenprodil Phase 2b/3 COVID, Algernon Pharmaceuticals Announces Plans to Provide Interim Data from its Ifenprodil Phase 2b/3 COVID-19 Human Study, Algernon Pharmaceuticals Announces Green Light From Data and Safety Monitoring Board to Continue its Multinational 2b/3 Human, Algernon Pharmaceuticals Announces 25% Enrollment in its Ifenprodil IPF and Chronic Cough Phase 2 Human Study, Algernon Pharmaceuticals Appoints Dr. Mark Swaim MD, PhD to its Medical and Scientific Advisory Board, Algernon Announces 75% Enrollment in Multinational Phase 2b/3 Human Study of Ifenprodil for Treatment of COVID-19, Algernon Announces Enrollment of 100 Patients in Multinational 2b/3 Human Study of Ifenprodil for Treatment of COVID-19, Algernon Announces 50% Enrollment in Multinational 2b/3 Human Study of Ifenprodil for Treatment of COVID-19, Algernon Announces Data and Safety Monitoring Board Recommends the Continuation of its Multinational 2b/3 Human Study of, Algernon Announces Enrollment of 50th Patient in Multinational 2b/3 Human Study of Ifenprodil for Treatment of COVID-19, Marathon's Richards Sees Opportunity in Distressed Assets, 700 West Pender Street You will receive alerts when there are new announcements on Algernon Pharmaceuticals Inc. Only registered members can use this feature. Based on our forecasts, a long-term increase is expected, the "AGNPF" stock price prognosis for 2025-10-31 is 1.171 USD. AGNPF - Algernon Pharmaceuticals Inc Stock quote - CNNMoney.com Markets Canna Trader Pro. Shares in Algernon Pharmaceuticals Inc are currently priced at C$0.25. Puedes cambiar tus opciones en cualquier momento visitando Tus controles de privacidad. News Releases. If you're not sure which aus oder wählen Sie 'Einstellungen verwalten', um weitere Informationen zu erhalten und eine Auswahl zu treffen. The Company is focused on the areas of nonalcoholic steatohepatitis (NASH), chronic kidney disease (CKD) and inflammatory bowel disease (IBD). You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives. Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world. 0.0  0.0%. At that level they are trading at 0.22% discount to the analyst consensus target price of 0.00. Algernon Pharmaceuticals is a clinical stage pharmaceutical development company focused on the areas of non–alcoholic steatohepatitis (NASH), chronic kidney disease (CKD) and inflammatory bowel disease (IBD). DDE w/Realtime (Monthly) Monthly Subscription. VAT not included. View daily, weekly or monthly … It should only be considered an indication and not a recommendation. Algernon Pharmaceuticals Announces Green Light From Data and Safety Monitoring Board to Continue its Multinational 2b/3 Human Study of Ifenprodil for Treatment of … Currency in USD. Monthly Subscription. Algernon Pharmaceuticals Announces Green Light From Data and Safety Monitoring Board to Continue its Multinational 2b/3 Human Study of Ifenprodil for Treatment of COVID-19 October 30, 2020; Algernon Pharmaceuticals Announces 25% Enrollment in its Ifenprodil IPF and Chronic Cough Phase 2 Human Study October 13, 2020; Algernon Pharmaceuticals Appoints Dr. Mark Swaim MD, … Data delayed 15 minutes unless otherwise indicated. Shares in Algernon Pharmaceuticals Inc are currently trading at Before it's here, it's on the Bloomberg Terminal. View recent trades and share price information for Algernon Pharmaceuticals Inc and other shares. Widest with the analysis, Proactive gives perspectives that others don't. In order to claim this reduced rate on your behalf we require you to sign and return a W-8BEN form. Yahoo ist Teil von Verizon Media. Para obtener más información sobre cómo utilizamos tu información, consulta nuestra Política de privacidad y la Política de cookies. Algernon Pharmaceuticals (QB) (AGNPF) stock price, charts, trades & the US's most popular discussion forums. We may not share C$0.25, giving the company a market capitalisation of Monthly Subscription. Suite 915 Our website offers information about investing and saving, but not personal advice. Touch device users, explore by touch or with swipe gestures. access. C$0.25 Here are the top five shareholders of Algernon Pharmaceuticals Inc based on the size of their shareholding: © Stockopedia 2020, Refinitiv, Share Data Services. Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks, 700 Pender St W Suite 915, VANCOUVER, V6C 1G8, Canada, Algernon Pharmaceuticals Announces Plans to Provide Interim Data from its Ifenprodil Phase 2b/3 COVID-19 Human Study, BRIEF-Algernon Pharma Announces Green Light From Data And Safety Monitoring Board To Continue Multinational 2b/3 Human Study Of Ifenprodil For Treatment Of Covid-19, Algernon Pharmaceuticals Announces Green Light From Data and Safety Monitoring Board to Continue its Multinational 2b/3 Human Study of Ifenprodil for Treatment of COVID-19, Algernon Pharmaceuticals Announces 25% Enrollment in its Ifenprodil IPF and Chronic Cough Phase 2 Human Study. Your current $100 investment may be up to $626.29 in 2025. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC. Gold versus the VIX: which is the better bet, as US election uncertainty lingers? Algernon Pharmaceuticals Announces 25% Enrollment in its Ifenprodil IPF and Chronic Cough Phase 2 Human Study PRESS RELEASE GlobeNewswire Oct. 13, 2020, 08:00 AM Algernon Pharmaceuticals Inc We were not able to find PE ratio data for Algernon Pharmaceuticals Inc. We were unable to find the directors for Algernon Pharmaceuticals Inc.